Wolf Haldenstein Adler Freeman & Herz and Levi & Korsinsky filed a stockholder derivative suit Monday in California Southern District Court against Sorrento Therapeutics and members of its board. The complaint arises from the company’s development of STI-1499, intended as an antibody for COVID-19. The defendants are accused of misrepresenting STI-1499 as a viable cure while it was in the early stages of pre-clinical trials. Counsel have not yet appeared for the defendants. The case is 3:21-cv-01331, Chaudhari v. Ji et al.
This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.